Agilent Technologies Inc. has introduced the SureScan Microarray Scanner, the latest innovation in scanner technology and the foundation of Agilent’s complete microarray solution for both gene ...
Agilent Technologies Inc. has announced that the China Food and Drug Administration has approved the company’s SureScan Dx microarray scanner as a medical device for in vitro diagnostic use. “Bringing ...
(MENAFN- Ameliorate Digital Consultancy) The global Microarray Scanner market is projected to reach USD 5.52 billion by 2023, at a CAGR of 7.8%. The major factors driving the growth of this market are ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) announced it has obtained clearance from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the GenetiSure Dx ...
PALO ALTO, Calif. & BOSTON--(BUSINESS WIRE)--April 13, 2004--Agilent Technologies Inc. (NYSE:A) and Partners HealthCare System today announced a one-year agreement for Agilent to provide microarray ...
Agilent Technologies Inc. and Oxford Gene Technology (OGT) announced they have expanded an existing partnership into an exclusive agreement for Agilent to provide OGT with oligonucleotide microarrays ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results